πŸ‡ΊπŸ‡Έ FDA
Patent

US 8293803

Retinoid compounds and their use

granted A61KA61K31/216A61K31/235

Quick answer

US patent 8293803 (Retinoid compounds and their use) held by Reinnervate Limited expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Reinnervate Limited
Grant date
Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/216, A61K31/235, A61P, A61P17/02